Skip to content
Disclosery

EXANE DERIVATIVES: SLV position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on SLV, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 799 SLV shares at 2022-06-30 per its 13F-HR filed 2022-07-12.

the latest 13F is the newest step

  1. period ended2022-06-30
    13F 799 shares
    Change vs previous 13F 0 shares

    0.01% of the 13F portfolio, value $14,892.

    13F-HR 0001623883-22-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2022-03-31
    13F 799 shares
    Change vs previous 13F -4,000 shares

    0.01% of the 13F portfolio, value $18,281.

    13F-HR 0001623883-22-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2021-12-31
    13F 4,799 shares
    Change vs previous 13F 0 shares

    0.03% of the 13F portfolio, value $103,228.

    13F-HR 0001623883-22-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2021-09-30
    13F 4,799 shares
    Change vs previous 13F -4,852 shares

    0.02% of the 13F portfolio, value $98,477.

    13F-HR 0001623883-21-000008 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2021-06-30
    13F 9,651 shares
    Change vs previous 13F -7,713 shares

    0.05% of the 13F portfolio, value $232,398.

    13F-HR 0001623883-21-000006 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2021-03-31
    13F 17,364 shares
    Change vs previous 13F 0 shares

    0.12% of the 13F portfolio, value $394,169.

    13F-HR 0001623883-21-000004 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2020-12-31
    13F 17,364 shares
    Change vs previous 13F -5,517 shares

    0.13% of the 13F portfolio, value $426,640.

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2020-09-30
    13F/A 22,881 shares
    Change vs previous 13F not available

    0.16% of the 13F portfolio, value $495,143.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).